Amyloidosis Alliance The Voice of Patients

Research

Clinical trials

Every amyloidosis study now recruiting, about to open, or enrolling by invitation, anywhere in the world, listed straight from ClinicalTrials.gov and refreshed every day.

Information, not medical advice. The Alliance does not run these studies and cannot enrol you in one. If a trial looks relevant, discuss it with the doctor who follows your amyloidosis.

Recruiting and upcoming studies

The list covers AL, ATTR and AA amyloidosis as well as cerebral amyloid angiopathy. Each card says where the study stands: open to anyone who meets its criteria, not yet open, or restricted to people the investigators invite. Studies that close simply leave the list.

Showing 121–132 of 202 trials

RecruitingAL (light chain)

A Registry of AL Amyloidosis (ReAL) (opens on ClinicalTrials.gov)

The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.

Study
Observational (registry, imaging)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia

Recruiting in: Italy

NCT04839003Updated 16 April 2026

RecruitingATTR (transthyretin)

A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis. (opens on ClinicalTrials.gov)

The study is conducted in participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a heart disease that occurs in people with the disease ATTR amyloidosis. The…

Study
Interventional (treatment)
Phase
Phase 1
Sponsor
Novo Nordisk A/S

Recruiting in: Netherlands

NCT07448623Updated 13 April 2026

Not yet recruitingNot specified

CAR-NK Therapy for Cardiac Amyloidosis (opens on ClinicalTrials.gov)

Relapsed/refractory (R/R) light chain cardiac amyloidosis is associated with a poor prognosis, and cellular immunotherapy constitutes a crucial therapeutic modality for these patients. The…

Study
Interventional (treatment)
Phase
Phase 1
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine

No study locations listed yet

NCT07504289Updated 31 March 2026

RecruitingCerebral amyloid angiopathy

SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA) (opens on ClinicalTrials.gov)

Cerebral amyloid angiopathy (CAA) is one of the major types of cerebral small vessel disease, and a leading cause of spontaneous intracerebral hemorrhage and…

Study
Observational (registry, imaging)
Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Recruiting in: Italy

NCT04204642Updated 30 March 2026

RecruitingATTR (transthyretin)

The Italian Transthyretin Amyloidosis Web-Network (opens on ClinicalTrials.gov)

The study aims, by generating a large registry of patients with ATTR amyloidosis, including data at diagnosis and during follow up, to describe the…

Study
Observational (registry, imaging)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia

Recruiting in: Italy

NCT05444920Updated 27 March 2026

RecruitingATTR (transthyretin)

Comprehensive Program for Hereditary Transthyretin Amyloidosis (opens on ClinicalTrials.gov)

The Comprehensive Program for Hereditary Transthyretin Amyloidosis describes a prospective observational study focused on understanding hereditary transthyretin amyloidosis (ATTR), a progressive and potentially fatal…

Study
Observational (registry, imaging)
Sponsor
Hospital de Alta Complejidad en Red

Recruiting in: Argentina

NCT07213297Updated 24 March 2026

This list only covers amyloidosis studies that are open or about to open. The registry holds every study, including those already completed.

Search all studies on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov (U.S. National Library of Medicine). List last retrieved on 7 November 2026. clinicaltrials.gov

Not sure where to start?

Our member associations know the teams running these studies in their own country, and can help you prepare the conversation with your doctor.

Find an association near you
Contact the Alliance